Literature DB >> 18703170

Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia.

M Alpa1, B Ferrero, R Cavallo, C Naretto, E Menegatti, D Di Simone, F Napoli, R La Grotta, D Rossi, S Baldovino, L M Sena, D Roccatello.   

Abstract

Mixed cryoglobulinemia (MC) is an immunological disorder characterized by immune-complex-mediated systemic vasculitis involving small vessels, which may present with renal, cutaneous, rheumatologic, and/or neurological manifestations. Until recently, the possible appearance of anti-neuronal autoantibodies in peripheral neuropathy occurring in the context of hepatitis C virus (HCV)-associated IgMk/IgG MC has not been extensively addressed. Therefore, a sample of these patients were evaluated by means of immuno-enzyme methods of anti-neuronal autoantibody detection. A significant increase in plasma titers of both anti-GM1 ganglioside and anti-sulfatide was observed. Abnormal titers were associated with evidence of active neuropathy as assessed by electrophysiologic studies. While peripheral neuropathy was traditionally thought to result from axonal ischemic damage caused by deposits of cryoprecipitable immune complexes in the vasa nervorum, a significant association between anti-GM1 and anti-sulfatide antibodies and involvement of the peripheral nervous system was observed in HCV-associated mixed IgMk/IgG cryoglobulinemia. Anti-neuronal reactivity could be a direct trigger of neurologic injury in this disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703170     DOI: 10.1016/j.autrev.2008.07.027

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  8 in total

Review 1.  Diagnosis and therapeutic options for peripheral vasculitic neuropathy.

Authors:  Franz Blaes
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-04       Impact factor: 5.346

Review 2.  Role of sulfatide in normal and pathological cells and tissues.

Authors:  Tadanobu Takahashi; Takashi Suzuki
Journal:  J Lipid Res       Date:  2012-05-22       Impact factor: 5.922

3.  NKT-cell subsets: promoters and protectors in inflammatory liver disease.

Authors:  Vipin Kumar
Journal:  J Hepatol       Date:  2013-05-10       Impact factor: 25.083

Review 4.  Hepatitis C virus and autoimmunity.

Authors:  Barbara C Böckle; Norbert T Sepp
Journal:  Auto Immun Highlights       Date:  2010-07-10

5.  Regulation of alternative splicing in obesity-induced hypertension.

Authors:  Zodwa Dlamini; Rodney Hull; Tshepiso J Makhafola; Mzwandile Mbele
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-28       Impact factor: 3.168

Review 6.  Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.

Authors:  Takashi Himoto; Tsutomu Masaki
Journal:  Clin Dev Immunol       Date:  2012-09-05

Review 7.  HCV-related central and peripheral nervous system demyelinating disorders.

Authors:  Sara Mariotto; Sergio Ferrari; Salvatore Monaco
Journal:  Inflamm Allergy Drug Targets       Date:  2014

Review 8.  The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?

Authors:  Daniel S Smyk; Athanasios Mavropoulos; Giorgina Mieli-Vergani; Diego Vergani; Marco Lenzi; Dimitrios P Bogdanos
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.